The pBK-CMV-HA-EBP50 plasmid was used to upregulate EBP50 expression in pancreatic cancer cells and identify whether β-catenin/E-cadherin is directly targeted by its effects on the growth and invasion of pancreatic cancer cells. The gene discussed is NHERF1; the disease is familial pancreatic carcinoma.